HYDROXY-PHENYLBUTAZONE (TANDERIL) IN THE TREATMENT OF OCULAR DISEASE: A PRELIMINARY SURVEY

. 1960 Dec;44(12):755–760. doi: 10.1136/bjo.44.12.755

HYDROXY-PHENYLBUTAZONE (TANDERIL) IN THE TREATMENT OF OCULAR DISEASE

A PRELIMINARY SURVEY

PMCID: PMC510033 PMID: 13784471

These references are in PubMed. This may not be the complete list of references from this article.

GRAHAM W. The status of G-27202 (metabolite 1 of phenylbutazone) in the treatment of rheumatic disorders. Can Med Assoc J. 1960 May 14;82:1005–1008. [PMC free article] [PubMed] [Google Scholar]
HART F. D., BURLEY D. Phenylbutazone and its derivatives with special reference to G.27202. Br Med J. 1959 Apr 25;1(5129):1087–1089. doi: 10.1136/bmj.1.5129.1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
PERKINS E. S. The aetiology and treatment of uveitis. Trans Opthal Soc U K. 1958;78:511–522. [PubMed] [Google Scholar]
SVANE-KNUDSEN P. Phenylbutazon og dets anvendelse i ophthalmologien. Nord Med. 1959 Feb 5;61(6):226–228. [PubMed] [Google Scholar]